Institute of Clinical and Molecular Virology

J100: A TRM-inducing mucosal vaccination against lung-metastasizing cancer Jan. 1, 2023 - Dec. 31, 2025 P165-OA: Lipid nanoparticles for targeted delivery of HIV-1 antigens and genetic immunomodulators Jan. 1, 2025 - Dec. 31, 2025 Milk Transmission of Viruses: Prevention of mother to child transmission of Human T-cell leukemia Virus Type 1 (HTLV-1) (Milk-TV) Nov. 1, 2020 - Oct. 31, 2025 P147: Modelling the intestinal barrier to analyse HTLV-1 transmission Nov. 1, 2024 - Oct. 31, 2025 A101: Atypical, anti-viral IgG4 antibody responses after SARS-CoV-2 mRNA vaccination April 1, 2023 - Sept. 30, 2025 Interferenz mit der Spaltung des viralen Proteins p12: Auswirkungen auf Transmission und Persistenz des onkogenen Retrovirus Humanes T-Zell-Leukämie-Virus Typ 1 (VI-Pfleger-Stiftung_virale Protein p12) Aug. 1, 2024 - July 31, 2025 A096: Molecular and functional analysis of immune/ intestinal epithelial cell-interaction during CMV infection Jan. 1, 2023 - June 30, 2025 Inducing long-lasting HIV Env-specific antibody responses by intrastructural help Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention Oct. 1, 2019 - March 31, 2024 P099: Influence of the translocated microbiome on the TCR repertoire April 16, 2022 - Jan. 15, 2024 Identification of host restriction factors against Human T-cell leukemia virus (BFHZ_Mobilitätsbeih._ER-Montpellier) Aug. 5, 2014 - Dec. 31, 2023